Stanford Medicine pediatric hematologist Agnieszka Czechowicz, MD, Ph.D., has devoted her research career to improving ...
When a patient is diagnosed with osteosarcoma, an aggressive form of bone cancer, the mission is to remove the tumor entirely. Leaving behind even a microscopic cluster of malignant cells can be the ...
Multicancer assays leverage cfDNA methylation patterns to detect malignancy and infer tumor origin, with reported tissue-of-origin prediction approaching 87% accuracy in real-world experience. The 142 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results